Vipan Kumar
Vipan Kumar has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Prabhakar Kumar Verma
Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India
3 shared publications Aakash Deep
Department of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani, Haryana, India
1 shared publication- Abdulrahman Alshammari
Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
1 shared publication - Amit Lather
Department of Pharmacology, Hindu College of Pharmacy, Sonipat-131001, India
1 shared publication - Amruta Suryan
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
1 shared publication Anu Dhanda
1 shared publication
Latest Publications
- 3 August 2026
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 22, 1-5
From Docking Scores to Biological Relevance: Strengthening Experimental Validation in Medicinal Chemistry Research
- 3 August 2026
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 22, 1-5
From Docking Scores to Biological Relevance: Strengthening Experimental Validation in Medicinal Chemistry Research
- Open Access
- 30 March 2026
- Published by AMG Transcend Association in Letters in Applied NanoBioScience
- Vol. 15 (1)
Exploring the Therapeutic Promise of Naphthoquinones: A Spotlight on Lapachol
Medicinal plants possess various biological activities and significantly contribute towards the development of various clinically used medications. In recent years, the research interest in natural drug designs has increased exponentially. Lapachol is a useful phytoconstituent with a quinone ring, reported for its broad-spectrum pharmacological activities, including antimicrobial, anticancer, anti-leishmanial, anti-trypanosomal, molluscicidal, wound-healing, and other activities. The therapeutic values of Lapachol from various plant families have been explored in existing scientific reports, as well as in traditional uses and other potential therapeutic effects. This review highlights updates on the pharmacological activities and other traditional uses of Lapachol.
- 30 March 2026
- Published by AMG Transcend Association in Letters in Applied NanoBioScience
- Vol. 15 (1)
Open AccessExploring the Therapeutic Promise of Naphthoquinones: A Spotlight on Lapachol
Medicinal plants possess various biological activities and significantly contribute towards the development of various clinically used medications. In recent years, the research interest in natural drug designs has increased exponentially. Lapachol is a useful phytoconstituent with a quinone ring, reported for its broad-spectrum pharmacological activities, including antimicrobial, anticancer, anti-leishmanial, anti-trypanosomal, molluscicidal, wound-healing, and other activities. The therapeutic values of Lapachol from various plant families have been explored in existing scientific reports, as well as in traditional uses and other potential therapeutic effects. This review highlights updates on the pharmacological activities and other traditional uses of Lapachol.
- 20 September 2025
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 62 (12) , 1898-1915
Exploring Synthetic Strategies and Therapeutic Potential of Naphthoquinone Derivatives: A Review
Naphthoquinone derivatives are increasingly recognized for their wide‐ranging biological activities and relevance in drug discovery. This review outlines recent advances in the synthesis of naphthoquinone compounds, focusing on strategies that enhance their structural diversity and efficiencies. We explored their broad therapeutic potential, including strong antimicrobial effects against both gram‐negative and gram‐positive pathogens and their capacity to overcome microbial resistance. Their antimalarial activity also shows promise, offering new options for the treatment of drug‐resistant species. In oncology, several derivatives have demonstrated selective cytotoxicity against cancer cell lines, with distinct mechanisms supporting their development as anticancer agents. Additionally, their antioxidant properties offer protection against oxidative stress, which has implications for chronic diseases and aging‐related disorders. Emerging data also indicate neuroprotective effects, particularly in Alzheimer's disease, by modulating oxidative stress and neuroinflammation. These findings underscore the versatility of naphthoquinone derivatives as potential leads in multiple therapeutic areas. By compiling synthetic methods and biological insights, this review provides a comprehensive resource to support future research and the development of naphthoquinone‐based drug candidates.
- 20 September 2025
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 62 (12) , 1898-1915
Exploring Synthetic Strategies and Therapeutic Potential of Naphthoquinone Derivatives: A Review
Naphthoquinone derivatives are increasingly recognized for their wide‐ranging biological activities and relevance in drug discovery. This review outlines recent advances in the synthesis of naphthoquinone compounds, focusing on strategies that enhance their structural diversity and efficiencies. We explored their broad therapeutic potential, including strong antimicrobial effects against both gram‐negative and gram‐positive pathogens and their capacity to overcome microbial resistance. Their antimalarial activity also shows promise, offering new options for the treatment of drug‐resistant species. In oncology, several derivatives have demonstrated selective cytotoxicity against cancer cell lines, with distinct mechanisms supporting their development as anticancer agents. Additionally, their antioxidant properties offer protection against oxidative stress, which has implications for chronic diseases and aging‐related disorders. Emerging data also indicate neuroprotective effects, particularly in Alzheimer's disease, by modulating oxidative stress and neuroinflammation. These findings underscore the versatility of naphthoquinone derivatives as potential leads in multiple therapeutic areas. By compiling synthetic methods and biological insights, this review provides a comprehensive resource to support future research and the development of naphthoquinone‐based drug candidates.
- Open Access
- 1 May 2024
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 32 (5) , 102046
Amphiphilic, lauric acid-coupled pluronic-based nano-micellar system for efficient glipizide delivery
Glipizide; an insulin secretagogue belonging to the sulfonylurea class, is a widely used antidiabetic drug for managing type 2 diabetes. However, the need for life-long administration and repeated doses poses challenges in maintaining optimal blood glucose levels. In this regard, orally active sustained-release nano-formulations can be a better alternative to traditional antidiabetic formulations. The present study explored an innovative approach by formulating orally active sustained-release nano-micelles using the amphiphilic lauric acid-conjugated-F127 (LAF127) block copolymer. LAF127 block copolymer was synthesized through esterification and thoroughly characterized before being employed to develop glipizide-loaded nano-micelles (GNM) via the thin-film hydration technique. The optimized formulation exhibited mean particle size of 341.40 ± 3.21 nm and depicted homogeneous particle size distribution with a polydispersity index (PDI) < 0.2. The formulation revealed a surface charge of −17.11 ± 6.23 mV. The in vitro release studies of glipizide from developed formulation depicted a sustained release profile. Drug loaded micelles exhibited a substantial reduction in blood glucose levels in diabetic rats for a duration of up to 24 h. Notably, neither the blank nano-micelles of LAF127 nor the drug loaded micelles manifested any indications of toxicity in healthy rats. This study provides an insight on suitability of synthesized LAF127 block copolymer for development of effective oral drug delivery systems for anti-diabetic activity without any significant adverse effects.
- 1 May 2024
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 32 (5) , 102046
Open AccessAmphiphilic, lauric acid-coupled pluronic-based nano-micellar system for efficient glipizide delivery
Glipizide; an insulin secretagogue belonging to the sulfonylurea class, is a widely used antidiabetic drug for managing type 2 diabetes. However, the need for life-long administration and repeated doses poses challenges in maintaining optimal blood glucose levels. In this regard, orally active sustained-release nano-formulations can be a better alternative to traditional antidiabetic formulations. The present study explored an innovative approach by formulating orally active sustained-release nano-micelles using the amphiphilic lauric acid-conjugated-F127 (LAF127) block copolymer. LAF127 block copolymer was synthesized through esterification and thoroughly characterized before being employed to develop glipizide-loaded nano-micelles (GNM) via the thin-film hydration technique. The optimized formulation exhibited mean particle size of 341.40 ± 3.21 nm and depicted homogeneous particle size distribution with a polydispersity index (PDI) < 0.2. The formulation revealed a surface charge of −17.11 ± 6.23 mV. The in vitro release studies of glipizide from developed formulation depicted a sustained release profile. Drug loaded micelles exhibited a substantial reduction in blood glucose levels in diabetic rats for a duration of up to 24 h. Notably, neither the blank nano-micelles of LAF127 nor the drug loaded micelles manifested any indications of toxicity in healthy rats. This study provides an insight on suitability of synthesized LAF127 block copolymer for development of effective oral drug delivery systems for anti-diabetic activity without any significant adverse effects.
- 2 November 2022
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (6) , 929-949
Pyridazinones: A versatile scaffold in the development of potential target‐based novel anticancer agents
Pyridazinones are important nitrogen‐rich heterocyclic core that has been driving the substantial medicinal interest due to their wide range of biological activities. This privileged scaffold forms a central core in numerous potent compounds, which results in the development of novel anticancer drugs with fruitful biological activities. The current review article summarizes the progressive development of novel pyridazinone derivatives that are targets for numerous receptors such as C‐met kinase inhibitors, PARP inhibitors, Tubulin polymerization inhibitors, Dihydro folate reductase inhibitors, B‐Raf inhibitors, Bruton tyrosine kinase inhibitors, FER tyrosine kinase inhibitors, and fibroblast growth factors receptors. It features the various simple techniques for the synthesis of pyridazinones and also highlights the mechanistic insights into the anticancer properties of pyridazinone derivatives.
- 2 November 2022
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (6) , 929-949
Pyridazinones: A versatile scaffold in the development of potential target‐based novel anticancer agents
Pyridazinones are important nitrogen‐rich heterocyclic core that has been driving the substantial medicinal interest due to their wide range of biological activities. This privileged scaffold forms a central core in numerous potent compounds, which results in the development of novel anticancer drugs with fruitful biological activities. The current review article summarizes the progressive development of novel pyridazinone derivatives that are targets for numerous receptors such as C‐met kinase inhibitors, PARP inhibitors, Tubulin polymerization inhibitors, Dihydro folate reductase inhibitors, B‐Raf inhibitors, Bruton tyrosine kinase inhibitors, FER tyrosine kinase inhibitors, and fibroblast growth factors receptors. It features the various simple techniques for the synthesis of pyridazinones and also highlights the mechanistic insights into the anticancer properties of pyridazinone derivatives.
- 25 August 2022
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (2) , 183-200
Synthesis and antimycobacterial evaluation of pyrazinamide, benzimidazole and carboxamide derivatives
Due to the unusual structure and chemical composition of the mycobacterial cell wall, it is difficult to develop effective antitubercular treatment as it leads to many antibiotics not working and preventing drug entry. It also leads to the problem of more drug resistance. Tuberculosis (TB) is still the second most contagious disease with about 33% of the world's population being affected mainly by drug‐resistant TB (MDR, XDR), chronic infections, and the combination of TB and human immunodeficiency virus (HIV). Therefore, there is an urgent need for the development of novel antitubercular drugs that will shorten the total duration of effective treatment taken under directly observed treatment, short‐course (DOTS) guidance, solve the problem of multiple drug resistance, and provide effective treatment for TB diseases. In this review, we considered various synthetic schemes of pyrazinamide, benzimidazole, and carboxamide derivatives that have antitubercular properties that can overcome the resistance to parental drugs and thus act as an effective alternative.
- 25 August 2022
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (2) , 183-200
Synthesis and antimycobacterial evaluation of pyrazinamide, benzimidazole and carboxamide derivatives
Due to the unusual structure and chemical composition of the mycobacterial cell wall, it is difficult to develop effective antitubercular treatment as it leads to many antibiotics not working and preventing drug entry. It also leads to the problem of more drug resistance. Tuberculosis (TB) is still the second most contagious disease with about 33% of the world's population being affected mainly by drug‐resistant TB (MDR, XDR), chronic infections, and the combination of TB and human immunodeficiency virus (HIV). Therefore, there is an urgent need for the development of novel antitubercular drugs that will shorten the total duration of effective treatment taken under directly observed treatment, short‐course (DOTS) guidance, solve the problem of multiple drug resistance, and provide effective treatment for TB diseases. In this review, we considered various synthetic schemes of pyrazinamide, benzimidazole, and carboxamide derivatives that have antitubercular properties that can overcome the resistance to parental drugs and thus act as an effective alternative.
- 23 September 2021
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 18 (7) , 635-649
New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments
Since December 2019, the prevalence of novel coronavirus infection (named as COVID- 19 by WHO on Feb 11, 2020) has become a growing healthcare concern worldwide. On March 11, 2020, the WHO declared COVID-19 a global pandemic. As no specific approved treatment options are available for the COVID-19 infection, several existing antiviral drugs in combination with others have become the mainstay therapy. The targets for the treatment of the infection include viral targets such as polymerases, spike glycoproteins, membrane proteins, and viral envelope and host targets such as host proteases and host receptors. Antiviral agents, immunomodulatory agents, and empiric broad-spectrum antibiotics can be used as treatment therapies for the infection. Convalescent plasma therapy has also been proposed as an effective treatment for COVID-19. Additionally, many studies are ongoing to develop a potent and effective vaccine that completely blocks SARS-CoV-2. Nevertheless, prevention of spread of the virus remains the first and foremost step towards controlling and managing the coronavirus infection.
- 23 September 2021
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 18 (7) , 635-649
New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments
Since December 2019, the prevalence of novel coronavirus infection (named as COVID- 19 by WHO on Feb 11, 2020) has become a growing healthcare concern worldwide. On March 11, 2020, the WHO declared COVID-19 a global pandemic. As no specific approved treatment options are available for the COVID-19 infection, several existing antiviral drugs in combination with others have become the mainstay therapy. The targets for the treatment of the infection include viral targets such as polymerases, spike glycoproteins, membrane proteins, and viral envelope and host targets such as host proteases and host receptors. Antiviral agents, immunomodulatory agents, and empiric broad-spectrum antibiotics can be used as treatment therapies for the infection. Convalescent plasma therapy has also been proposed as an effective treatment for COVID-19. Additionally, many studies are ongoing to develop a potent and effective vaccine that completely blocks SARS-CoV-2. Nevertheless, prevention of spread of the virus remains the first and foremost step towards controlling and managing the coronavirus infection.
- 14 February 2019
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 56 (4) , 1376-1382
Synthesis, Antimicrobial, and Antioxidant Screening of Aryl Acetic Acid Incorporated 1,2,4‐Triazolo‐1,3,4‐Thiadiazole Derivatives
Some novel [1,2,4]triazolo[3,4‐b][1,3,4]thiadiazole derivatives were synthesized from aryl acetic acids. All the synthesized derivatives were selected for the screening of antibacterial potential against Gram‐positive bacteria [Staphylococcus aureus (MTCC 3160) and Micrococcus luteus (MTCC 1538)] and Gram‐negative bacteria [Escherichia coli (MTCC 1652) and Pseudomonas aeruginosa (MTCC 424)] and antifungal potential against Aspergillus niger (MTCC 8652) and Candida albicans (MTCC 227), and free radical scavenging activity through 2,2‐diphenyl‐2‐picrylhydrazyl hydrate method. The compounds TH‐4, TH‐13, and TH‐19 were found to be more potent antimicrobial agents compared to standard drugs. The compounds TH‐3, TH‐9, and TH‐18 also showed significant antimicrobial activity. The compound TH‐13 showed antioxidant activity with IC50 value better than the standard compound. The structures of all the synthesized compounds were confirmed by Fourier transform infrared, 1H‐NMR, liquid chromatography–mass spectrometry, and CHN analyzer.
- 14 February 2019
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 56 (4) , 1376-1382
Synthesis, Antimicrobial, and Antioxidant Screening of Aryl Acetic Acid Incorporated 1,2,4‐Triazolo‐1,3,4‐Thiadiazole Derivatives
Some novel [1,2,4]triazolo[3,4‐b][1,3,4]thiadiazole derivatives were synthesized from aryl acetic acids. All the synthesized derivatives were selected for the screening of antibacterial potential against Gram‐positive bacteria [Staphylococcus aureus (MTCC 3160) and Micrococcus luteus (MTCC 1538)] and Gram‐negative bacteria [Escherichia coli (MTCC 1652) and Pseudomonas aeruginosa (MTCC 424)] and antifungal potential against Aspergillus niger (MTCC 8652) and Candida albicans (MTCC 227), and free radical scavenging activity through 2,2‐diphenyl‐2‐picrylhydrazyl hydrate method. The compounds TH‐4, TH‐13, and TH‐19 were found to be more potent antimicrobial agents compared to standard drugs. The compounds TH‐3, TH‐9, and TH‐18 also showed significant antimicrobial activity. The compound TH‐13 showed antioxidant activity with IC50 value better than the standard compound. The structures of all the synthesized compounds were confirmed by Fourier transform infrared, 1H‐NMR, liquid chromatography–mass spectrometry, and CHN analyzer.
- Open Access
- 7 August 2018
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- Vol. 11 (8) , 212-217
PREPARATION AND CHARACTERIZATION OF METFORMIN LOADED STEARIC ACID COUPLED F127 NANOPARTICLES
Objective: The objective of this study was to prepare and evaluate metformin nanoparticles (MN) using stearic acid-coupled F127 (SAF127) copolymer and polyvinyl alcohol by emulsion solvent evaporation technique.Method: Metformin is the first-line drug for the treatment of type II diabetes mellitus belongs to Biopharmaceutical Classification System Class III. The prepared MN was characterized for particle size, polydispersity index (PDI), zeta potential, drug entrapment, percentage yield, in vitro drug release, and stability studies. The compatibility studies were performed by Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC). The crystallographic and surface properties were studied by X-ray diffractometry and scanning electron microscopy, respectively.Results: The mean particle diameter of prepared nanoparticles ranged from 207.8 to 977.64 nm, PDI value ranged from 0.146 to 0.694, and zeta potential ranged from −20.5 to −6.97 mV. The drug entrapment efficiency of these nanoparticles varies between 18.81 to 69.01 %. The drug to SAF127 copolymer (10/30 w/w) ratio (MN3) showed optimum results. The MN3 had spherical morphology with semi-amorphous nature. The results of FTIR and DSC analysis showed that there was no significant interaction between drug and excipients. The prepared polymeric nanoparticles were stable at 5±3°C up to 3 months. In vitro release of drug from MN3 was 20.52% in the first 1 h and remaining drug was released up to 30 h.Conclusion: The results of this study confirmed the sustained drug release profile of metformin loaded SAF127 copolymer nanoparticles. These nanoparticles can be best stored up to 3 months.
- 7 August 2018
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- Vol. 11 (8) , 212-217
Open AccessPREPARATION AND CHARACTERIZATION OF METFORMIN LOADED STEARIC ACID COUPLED F127 NANOPARTICLES
Objective: The objective of this study was to prepare and evaluate metformin nanoparticles (MN) using stearic acid-coupled F127 (SAF127) copolymer and polyvinyl alcohol by emulsion solvent evaporation technique.Method: Metformin is the first-line drug for the treatment of type II diabetes mellitus belongs to Biopharmaceutical Classification System Class III. The prepared MN was characterized for particle size, polydispersity index (PDI), zeta potential, drug entrapment, percentage yield, in vitro drug release, and stability studies. The compatibility studies were performed by Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC). The crystallographic and surface properties were studied by X-ray diffractometry and scanning electron microscopy, respectively.Results: The mean particle diameter of prepared nanoparticles ranged from 207.8 to 977.64 nm, PDI value ranged from 0.146 to 0.694, and zeta potential ranged from −20.5 to −6.97 mV. The drug entrapment efficiency of these nanoparticles varies between 18.81 to 69.01 %. The drug to SAF127 copolymer (10/30 w/w) ratio (MN3) showed optimum results. The MN3 had spherical morphology with semi-amorphous nature. The results of FTIR and DSC analysis showed that there was no significant interaction between drug and excipients. The prepared polymeric nanoparticles were stable at 5±3°C up to 3 months. In vitro release of drug from MN3 was 20.52% in the first 1 h and remaining drug was released up to 30 h.Conclusion: The results of this study confirmed the sustained drug release profile of metformin loaded SAF127 copolymer nanoparticles. These nanoparticles can be best stored up to 3 months.
- 20 October 2015
- Published by Taylor & Francis in Toxicological & Environmental Chemistry
- Vol. 97 (10) , 1408-1421
Structural and molecular alterations in arsenic-induced hepatic oxidative stress in rats: a FTIR study
Arsenic (As) is an ubiquitously distributed environmental toxicant predominantly contaminating drinking water. A number of studies indicated that oral exposure of humans to inorganic As produced damage to various body tissues including liver. Oxidative stress is thought to play a major role in As-induced hepatotoxicity. In this study, Fourier transforms infrared (FTIR) spectroscopy approach was applied to determine whether chronic As exposure at 25 ppm, intragastrically for 12 weeks, affected oxidative stress status in rat liver. Data demonstrated that chronic As administration exacerbated oxidative stress as was evidenced by suppressed antioxidant defense system and increased lipid peroxidation and protein oxidation. The FTIR study showed that peak area value of amide A decreased significantly followed by reduced amide I and amide II peak area in an As-treated rat liver suggesting altered protein profile. The change of Olefinic˭CH stretching band and C˭O stretching of triglycerides band indicated the altered lipid levels due to metallic exposure. The fall in the peak area of PO2− asymmetric stretching in the As-treated group might be due to compositional changes of nucleic acids. Hence, the results of this study indicate that As-induced oxidative stress was associated with structural and molecular modifications in proteins, lipids, and glycogen in a rat liver that may help to elucidate molecular mechanisms underlying metal-mediated hepatic damage.
- 20 October 2015
- Published by Taylor & Francis in Toxicological & Environmental Chemistry
- Vol. 97 (10) , 1408-1421
Structural and molecular alterations in arsenic-induced hepatic oxidative stress in rats: a FTIR study
Arsenic (As) is an ubiquitously distributed environmental toxicant predominantly contaminating drinking water. A number of studies indicated that oral exposure of humans to inorganic As produced damage to various body tissues including liver. Oxidative stress is thought to play a major role in As-induced hepatotoxicity. In this study, Fourier transforms infrared (FTIR) spectroscopy approach was applied to determine whether chronic As exposure at 25 ppm, intragastrically for 12 weeks, affected oxidative stress status in rat liver. Data demonstrated that chronic As administration exacerbated oxidative stress as was evidenced by suppressed antioxidant defense system and increased lipid peroxidation and protein oxidation. The FTIR study showed that peak area value of amide A decreased significantly followed by reduced amide I and amide II peak area in an As-treated rat liver suggesting altered protein profile. The change of Olefinic˭CH stretching band and C˭O stretching of triglycerides band indicated the altered lipid levels due to metallic exposure. The fall in the peak area of PO2− asymmetric stretching in the As-treated group might be due to compositional changes of nucleic acids. Hence, the results of this study indicate that As-induced oxidative stress was associated with structural and molecular modifications in proteins, lipids, and glycogen in a rat liver that may help to elucidate molecular mechanisms underlying metal-mediated hepatic damage.